Embed This Video

<object id="cnbcplayer" height="380" width="400" classid="clsid:D27CDB6E-AE6D-11cf-96B8-444553540000" codebase="http://download.macromedia.com/pub/shockwave/cabs/flash/swflash.cab#version=9,0,0,0" > <param name="type" value="application/x-shockwave-flash"/> <param name="allowfullscreen" value="true"/> <param name="allowscriptaccess" value="always"/> <param name="quality" value="best"/> <param name="scale" value="noscale" /> <param name="wmode" value="transparent"/> <param name="bgcolor" value="#000000"/> <param name="salign" value="lt"/> <param name="flashVars" value="startTime=000"/> <param name="flashVars" value="endTime=000"/> <param name="movie" value="http://plus.cnbc.com/rssvideosearch/action/player/id/3000209415/code/cnbcplayershare" /> <embed name="cnbcplayer" PLUGINSPAGE="http://www.macromedia.com/go/getflashplayer" allowfullscreen="true" allowscriptaccess="always" bgcolor="#000000" height="380" width="400" quality="best" wmode="transparent" scale="noscale" salign="lt" src="http://plus.cnbc.com/rssvideosearch/action/player/id/3000209415/code/cnbcplayershare" type="application/x-shockwave-flash" /></object>

Link To This Video

test

Rate This Video

2 Stars

3 Stars

4 Stars

5 Stars

(No Ratings Yet)

Loading...

Tags For This Video

Eli Lilly’s Q3 beats on top and bottom line

Posted on Nov 5, 2013 in Benchmarking and Metrics, Business News, Capital Markets, Economy, Financial Reporting, Strategy, Supply Chain, Technology

Eli Lilly’s Q3 beats on top and bottom line

We had strong revenue growth of six-percent, and three-percent of that growth was volume driven, says Derica Rice, Eli Lilly CFO, breaking down his company’s Q3 results and discussing several products the drugmaker has in the pipeline and growth areas in their animal health business, which grew at eleven percent.

Related Posts